Staphylococcus aureus bacteraemia with known sources

International Journal of Antimicrobial Agents
Ethan Rubinstein

Abstract

Meticillin-resistant Staphylococcus aureus (MRSA), both hospital-acquired and community-acquired MRSA (CA-MRSA) strains, have increased in frequency in the last few years, reaching epidemic dimensions. This review discusses several clinical forms of staphylococcal infection leading to bacteraemia in a high proportion of cases. Staphylococcal (MRSA) bacteraemic pneumonia is predominantly seen in hospital-acquired pneumonia and ventilator-associated pneumonia, reaching a frequency of 8.4% of all bacteraemias, 30% of all nosocomial bacteraemias and 68% of all bacteraemias of patients hospitalised in Intensive Care Units. In patients with CA-MRSA pneumonia, the rate of bacteraemia is as high as 62%. Whereas in nosocomial bacteraemic pneumonia blood cultures become positive on the ninth day of pneumonia, in CA-MRSA bacteraemic pneumonia positive blood cultures appear early in the course of the infection. The pneumonia has a stormy course with the development of abscesses, empyema and extensive pulmonary damage. Vertebral osteomyelitis commonly occurs during intravenous catheter use, causing local thrombophlebitis that will seed to vertebral bodies and disks and may cause secondary sustained bacteraemia. Non-vertebral osteomyelitis i...Continue Reading

References

Jul 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D WheelerS Keay
May 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G GunnarssonC Wanke
Sep 24, 2002·Archives of Disease in Childhood·K S WongS M Chu
Jul 4, 2003·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Carmen GonzálezJuan J Picazo
May 19, 2006·Emerging Infectious Diseases·Jeffrey C HagemanL Clifford McDonald
Jun 8, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Eric J Seeley, Henry F Chambers
Nov 10, 2006·The New England Journal of Medicine·Rabih O Darouiche
Jun 30, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yves GilletJerome Etienne
May 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy C JenkinsWilliam J Burman

❮ Previous
Next ❯

Citations

Apr 27, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Tamsin R SheenKelly S Doran
Feb 25, 2011·Psychology & Health·Hélène JoffeChristian Solberg
Apr 19, 2011·Natural Product Research·Uthai SakeeWanchai De-Eknamkul
Oct 3, 2009·European Heart Journal·Stuart A CookPaolo G Camici
Jun 22, 2011·Journal of Endodontics·Scott C HowellKevin A Guze
Jan 11, 2011·Médecine et maladies infectieuses·P Tattevin
Apr 7, 2010·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Masaaki HigashiyamaAkihiko Kawana
Jan 13, 2015·IEEE Transactions on Image Processing : a Publication of the IEEE Signal Processing Society·Kaibing ZhangZenggang Xiong
Sep 22, 2015·IEEE Transactions on Image Processing : a Publication of the IEEE Signal Processing Society· Qiang Qiu, Rama Chellappa
Jul 16, 2013·Scandinavian Journal of Infectious Diseases·Frédéric-Antoine DauchyMichel Dupon
Oct 10, 2015·IEEE Transactions on Pattern Analysis and Machine Intelligence·Chenglong BaoZuowei Shen
Apr 6, 2017·Medizinische Klinik, Intensivmedizin und Notfallmedizin·S WeisM W Pletz
Mar 27, 2018·Journal of Biomedical Optics·Ashkan AbbasiHossein Rabbani
Nov 29, 2017·Mediators of Inflammation·Florence AbdallahChantal Pichon
Sep 20, 2020·FEMS Microbiology Ecology·Vanessa SilvaPatrícia Poeta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

JAMA : the Journal of the American Medical Association
R Monina KlevensActive Bacterial Core surveillance (ABCs) MRSA Investigators
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
José F Siqueira
Journal of Clinical Periodontology
S S SocranskyR L Kent
© 2022 Meta ULC. All rights reserved